Deepika Pakianathan is Director at Karyopharm Therapeutics Inc. (KPTI). They have made 13 open-market trades across 6 companies since 2006, most recently 2026-06-12.
CIK 0001270734
8 open-market purchases totalling $26.0M since 2006, against 5 sales. Across 8 scored buys the stock is up 0.4% at ninety days, and 0.2 points ahead of the S&P over the same stretch.
8 scored purchases · one row per filing · discretionary only
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 0% | 50% | 50% |
| Avg Move | -37.1% | +0.4% | +0.4% |
| Alpha | -31.3% | +0.2% | +0.2% |
| Scored | 8 | 8 | 8 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| MREO | SELL | 2024-08-22 | 2024-08-23 | $4.43 | $932K | -9.6% | -16.5% | -24.9% |
| KPTI | SELL | 2024-06-05 | 2024-06-07 | $0.96 | $1.6M | -1.3% | -17.7% | -16.9% |
| KPTI | SELL | 2024-05-31 | 2024-06-04 | $0.96 | $1.4M | +3.4% | -11.5% | -22.2% |
| CALA | SELL | 2023-01-27 | 2023-01-31 | $0.39 | $47K | +715.0% | +715.0% | +715.0% |
| KPTI | SELL | 2022-06-08 | 2022-06-10 | $6.37 | $6.8M | -1.2% | -6.0% | +3.5% |
| KPTI | BUY | 2015-01-12 | 2015-01-14 | $33.00 | $1.5M | -46.9% | +3.0% | +3.0% |
| CALA | BUY | 2014-10-07 | 2014-10-09 | $10.00 | $5.0M | -32.6% | +0.3% | +0.3% |
| OMED | BUY | 2014-08-19 | 2014-08-21 | $18.98 | $1.5M | -32.1% | -0.5% | -0.5% |
| KPTI | BUY | 2014-05-21 | 2014-05-23 | $26.18 | $3.0M | -46.9% | +3.0% | +3.0% |
| ALDR | BUY | 2014-05-13 | 2014-05-15 | $10.00 | $3.5M | -19.9% | -2.2% | -2.2% |
| KPTI | BUY | 2013-11-12 | 2013-11-14 | $16.00 | $5.0M | -46.9% | +3.0% | +3.0% |
| OMED | BUY | 2013-07-23 | 2013-07-23 | $17.00 | $6.5M | -32.1% | -0.5% | -0.5% |
| ALXA | BUY | 2006-03-08 | 2006-03-09 | $8.00 | $8K | -39.4% | -2.5% | -2.5% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.
| KPTI |
| 15,508 |
| $1K |
| MREO | 1,825 | $553 |
| Total | $57.3M |
Shares reported on the most recent Form 4, priced at the 2026-06-16 close.